How to Choose Glucagon: Key Tips on Product Function & Attributes
Published: July 18, 2026 15:33
Author: Andreas Wang
Abstract: Glucagon, a 29-amino acid peptide, is critical for managing severe hypoglycemia. Choosing the right product requires analyzing purity (>98% by HPLC), stability (lyophilized vs. liquid), and delivery mechanism (nasal vs. injectable). Current market trends show a 7.2% CAGR (2024-2030), driven by biosimilar adoption and GLP-1 analog cross-utility. Leading brands (e.g., Eli Lilly’s Glucagon, Xeris’s Gvoke) differ in reconstitution time and shelf life. Key selection criteria include GMP-certified manufacturing, cold-chain logistics (2-8°C), and regulatory approvals (FDA/EMA). This guide integrates technical parameters, brand comparisons, and industry data to optimize peptide procurement for clinical efficacy and safety.